• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [24117 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2006     Institute for Clinical Evaluative Sciences (ICES) Physician services in rural and northern Ontario
2013     Penn Medicine Center for Evidence-based Practice (CEP) Physician training and credentialing for robotic surgery in obstetrics and gynecology
2018     Agency for Healthcare Research and Quality (AHRQ) Physiologic predictors of severe injury: systematic review
2001     VA Technology Assessment Program (VATAP) Physiologic telemonitoring in CHF
2014     Health Quality Ontario (HQO) Physiotherapy after knee arthroscopy: a rapid review
2002     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Physiotherapy in lymphedema postmastectomy
2005     Medical Advisory Secretariat (MAS) Physiotherapy rehabilitation after total knee or hip replacement: an evidence-based analysis
2019     National Institute for Health and Care Excellence (NICE) PICO negative pressure wound dressings for closed surgical incisions. NICE medical technologies guidance 43
2008     NIHR Horizon Scanning Centre (NIHR HSC) Picoplatin for small cell lung cancer - second line
1997     VA Technology Assessment Program (VATAP) Picture archiving and communication systems: a systematic review of published studies of diagnostic accuracy, radiology work processes, outcomes of care, and cost
2021     Ontario Health Pigmented lesion assay for suspected melanoma lesions
2010     HAYES, Inc. Pillar palatal implant system (Medtronic Xomed Inc.) for obstructive sleep apnea
2008     HAYES, Inc. Pillar palatal implant system (Restore Medical Inc.) for obstructive sleep apnea
2006     Adelaide Health Technology Assessment (AHTA) Pillar procedure for the treatment of obstructive sleep apnoea and snoring
2017     NIHR Health Technology Assessment programme Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines
2015     NIHR Public Health Research (PHR) programme Pilot study of a randomised trial of a guided e-learning health promotion intervention for managers based on management standards for the improvement of employee well-being and reduction of sickness absence: the GEM (Guided E-learning for Managers) study
2005     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Pilot test of the waiting list prioritisation system for cataract, knee & hip arthroplasty patients (September 2003)
2014     NIHR Horizon Scanning Centre (NIHR HSC) Pimavanserin tartrate for psychosis associated with Parkinson's disease - first line
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Pimecrolimus (Elidel (R)) for atopic dermatitis
2016     HTA Unit, University of Calgary Pineal gland cysts: an evidence synthesis
2016     HTA Unit, University of Calgary Pineal gland cysts: an evidence synthesis summary
2012     HAYES, Inc. Pipeline embolization device (Covidien ev3) for treatment of intracranial aneurysms
2011     HAYES, Inc. Pipeline embolization device (ev3 Inc.) for treatment of intracranial aneurysms
2012     National Institute for Health and Care Excellence (NICE) Pipeline Flex embolisation device with Shield Technology for the treatment of complex intracranial aneurysms. NICE medical technologies guidance 10
2009     NIHR Horizon Scanning Centre (NIHR HSC) Pirfenidone for idiopathic pulmonary fibrosis
2013     NIHR Health Technology Assessment programme Pirfenidone for the treatment of idiopathic pulmonary fibrosis
2018     National Institute for Health and Care Excellence (NICE) Pirfenidone for treating idiopathic pulmonary fibrosis. NICE technology appraisal guidance 504
2014     Malaysian Health Technology Assessment (MaHTAS) Piston-type mechanical chest compression
2012     NIHR Horizon Scanning Centre (NIHR HSC) Pitolisant for hypersomnia and narcolepsy in patients with Parkinson's disease
2016     NIHR Horizon Scanning Centre (NIHR HSC) Pitolisant hydrochloride for obstructive sleep apnoea
2022     National Institute for Health and Care Excellence (NICE) Pitolisant hydrochloride for treating excessive daytime sleepiness caused by obstructive sleep apnoea. NICE technology appraisal guidance 776
2002     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Pituitary hypophysial suppression in assisted human reproduction with Cetrorelix
2013     NIHR Horizon Scanning Centre (NIHR HSC) Pixantrone (Pixuvri) in combination with rituximab for diffuse large B-cell lymphoma or grade 3 follicular lymphoma – second and subsequent line
2009     NIHR Horizon Scanning Centre (NIHR HSC) Pixantrone dimaleate for relapsed or refractory aggressive non-Hodgkin's lymphoma
2013     NIHR Health Technology Assessment programme Pixantrone monotherapy for the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma
2014     National Institute for Health and Care Excellence (NICE) Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B-cell lymphoma. NICE technology appraisal guidance 306
2020     National Authority for Assessment and Accreditation in Healthcare (INEAS) Place des tests de diagnostic rapide dans la stratégie de prise en charge de la COVID-19
2020     National Authority for Assessment and Accreditation in Healthcare (INEAS) Place des tests de diagnostic rapide dans la stratégie de prise en charge de la COVID-19 : Complément d’informations du 22 Mai 2020
2003     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Place of molecular biology methods in detecting Chlamydia trachomatis infection of the lower genitourinary tract
2000     The Swedish Council on Health Technology Assessment (SBU) Placebo in health care - conference
2007     Adelaide Health Technology Assessment (AHTA) Placement of Acticon artificial bowel sphincters in the management of faecal incontinence
2003     Adelaide Health Technology Assessment (AHTA) Placement of artificial bowel sphincters in the management of faecal incontinence
1999     Medical Services Advisory Committee (MSAC) Placement of artificial bowel sphincters in the management of faecal incontinence
2003     Medical Services Advisory Committee (MSAC) Placement of artificial bowel sphincters in the management of faecal incontinence: assessment report
2009     National Institute for Health and Care Excellence (NICE) Placement of pectus bar for pectus excavatum (also known as MIRPE or the Nuss procedure). NICE interventional procedures guidance 310
2013     Malaysian Health Technology Assessment (MaHTAS) Placenta for cosmetic purpose and cell regeneration
2016     NIHR Health Technology Assessment programme Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis
2023     Ontario Health Placental growth factor (PlGF)-based biomarkers for risk prediction in people with suspected preeclampsia
2023     Scottish Health Technologies Group (SHTG) Placental growth factor (PlGF)-based testing to help diagnose suspected preterm pre-eclampsia
2011     NIHR Horizon Scanning Centre (NIHR HSC) Placental growth factor based tests for the diagnosis of pre-eclampsia
2006     Health Council of the Netherlands Gezondheidsraad (GR) Plan of campaign: promotion of healthy behaviour by mass media education
2003     Norwegian Knowledge Centre for the Health Services (NOKC) Planned caesarean section for breech birth at term - systematic review
2022     NIHR Health Technology Assessment programme Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial
2022     Health Information and Quality Authority (HIQA) Planned public health measures and strategies to limit the impact of COVID-19 surges: an international review
2015     NIHR Health Services and Delivery Research programme Planning for a cohort study to investigate the impact and management of influenza in pregnancy in a future pandemic
2001     Health Services Utilization and Research Commission (HSURC) Planning for Saskatchewan's future: population and health services projections to 2015
1993     Health Council of the Netherlands Gezondheidsraad (GR) Planning liver transplantations. Critical remarks on a draft-regulation
2022     NIHR Health Technology Assessment programme Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT
2000     HAYES, Inc. Plasma exchange for multiple sclerosis
2006     HAYES, Inc. Plasma exchange for multiple sclerosis
2014     HAYES, Inc. Plasma exchange for treatment of steroid-refractory transverse myelitis
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Plasma vaporization for the treatment of benign prostatic hypertrophy: clinical and cost-effectiveness, and safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Plasma Vaporization of the Prostate for Treatment of Benign Prostatic Hypertrophy: A review of clinical and cost-effectiveness, and safety
2024     Ontario Health Plasma-based comprehensive genomic profiling DNA assays for non-small cell lung cancer
2024     Ontario Health Plasma-based comprehensive genomic profiling DNA assays for non–small cell lung cancer: a health technology assessment
2012     HAYES, Inc. Plasmapheresis for hypertriglyceridemia-induced pancreatitis
2001     HAYES, Inc. Plasmapheresis for nonrenal indications
2001     ECRI Plasmapheresis for the treatment of multiple sclerosis
2005     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Platelet aggregation inhibitors in primary and secondary prevention of ischemic stroke
2013     HAYES, Inc. Platelet function assays for patients on antiplatelet therapy undergoing cardiac surgery
2019     NIHR Health Technology Assessment programme Platelet Rich Plasma (PRP) in Achilles Tendon Rupture (ATR) healing
2021     Malaysian Health Technology Assessment (MaHTAS) Platelet rich plasma (PRP), platelet-rich fibrin (PRF) and concentrated growth factor (CGF) for treatment of periodontal disease
2023     WorkSafeBC Platelet rich plasma as treatment for medial epicondylitis
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Platelet rich plasma for the treatment of tendinosis
2013     Malaysian Health Technology Assessment (MaHTAS) Platelet rich plasma for treatment of osteoarthritis
2023     WorkSafeBC Platelet rich plasma in treating (recurrent) anterior shoulder dislocation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Platelet rich plasma lumbar disc injections for lower back pain: clinical effectiveness, safety, and guidelines
2021     Malaysian Health Technology Assessment (MaHTAS) Platelet rich plasma, platele-rich fibrin (PRF) and concentrated growth factor (CGF) for treatment of periodontal disease
1998     University HealthSystem Consortium (UHC) Platelet transfusion guidelines
2011     HAYES, Inc. Platelet-rich plasma for ligament and tendon injuries
2012     HAYES, Inc. Platelet-rich plasma for ligament and tendon injuries
2019     National Institute for Health and Care Excellence (NICE) Platelet-rich plasma injections for knee osteoarthritis. NICE interventional procedures guidance 637
2007     Haute Autorite de sante (HAS) Platform posturography
2016     NIHR Health Technology Assessment programme PLEASANT: Preventing and Lessening Exacerbations of Asthma in School-age children Associated with a New Term a cluster randomised controlled trial and economic evaluation
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Pleconaril
2010     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Plerixafor (Mozobil) for autologous stem cell transplantation in patients with lymphoma and multiple myeloma
2007     NIHR Horizon Scanning Centre (NIHR HSC) Plerixafor (Mozobil) for stem-cell mobilisation in multiple myeloma
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Plerixafor (Mozobil®)
2017     Technology Assessment Unit of the McGill University Health Centre (MUHC) Plerixafor as first-line choice for stem cell mobilization in non-Hodgkin's lymphoma and multiple myeloma patients
2007     HAYES, Inc. Plethysmography for chronic venous insufficiency
2006     HAYES, Inc. Plethysmography for diagnosis of deep vein thrombosis of the legs
2016     HAYES, Inc. PleurX peritoneal catheter for home management of malignant ascites
2007     HAYES, Inc. Pleurx pleural catheter (Denver Biomedical Inc.) for home management of malignant pleural effusions
2022     National Institute for Health and Care Excellence (NICE) PLGF-based testing to help diagnose suspected preterm pre-eclampsia. NICE diagnostics guidance 49
2015     NIHR Horizon Scanning Centre (NIHR HSC) Plitidepsin (Aplidin) for relapsed and refractory multiple myeloma – fourth line
2013     NIHR Horizon Scanning Centre (NIHR HSC) Plitidepsin (Aplidin) in combination with dexamethasone for multiple myeloma – third line
2013     HAYES, Inc. PLP1-related disorders (including pelizaeus-merzbacher disease [PMD])
2021     National Institute for Health and Care Excellence (NICE) Plus Sutures for preventing surgical site infection. NICE medical technologies guidance 59
2011     HAYES, Inc. Pneumatic compression for prevention of deep vein thrombosis following hip surgery
2011     HAYES, Inc. Pneumatic compression for prevention of deep vein thrombosis following knee surgery